DrugPatentWatch Database Preview
HUMULIN R KWIKPEN Drug Profile
» See Plans and Pricing
Patent Text Search: US Patents for HUMULIN R KWIKPEN
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HUMULIN R KWIKPEN | insulin human | SOLUTION;SUBCUTANEOUS | 018780 | 002 | 1982-12-02 | Start Trial | SDG, Inc. (Cleveland, OH) | 2025-05-23 | RX | search | |
| Lilly | HUMULIN R KWIKPEN | insulin human | SOLUTION;SUBCUTANEOUS | 018780 | 002 | 1982-12-02 | Start Trial | REZOLUTE, INC. (Louisville, CO) | 2034-12-02 | RX | search | |
| Lilly | HUMULIN R KWIKPEN | insulin human | SOLUTION;SUBCUTANEOUS | 018780 | 002 | 1982-12-02 | Start Trial | InCube Labs, LLC (San Jose, CA) | 2034-05-15 | RX | search | |
| Lilly | HUMULIN R KWIKPEN | insulin human | SOLUTION;SUBCUTANEOUS | 018780 | 002 | 1982-12-02 | Start Trial | Novo Nordisk A/S (Bagsvaerd, DK) | 2028-03-18 | RX | search | |
| Lilly | HUMULIN R KWIKPEN | insulin human | SOLUTION;SUBCUTANEOUS | 018780 | 002 | 1982-12-02 | Start Trial | The Brigham and Women\'s Hospital, Inc. (Boston, MA) President and Fellows of Harvard College (Cambridge, MA) | 2034-10-14 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for HUMULIN R KWIKPEN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| German Democratic Republic | 209476 | Start Trial |
| Singapore | 11201503576X | Start Trial |
| Australia | 3119097 | Start Trial |
| Estonia | 03221 | Start Trial |
| Australia | 5988094 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for HUMULIN R KWIKPEN
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 122015000021 | Germany | Start Trial | PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720 |
| 14/2015 | Austria | Start Trial | PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720 |
| CA 2015 00017 | Denmark | Start Trial | PRODUCT NAME: TOBRAMYCIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/10/652/001-003 20110720 |
| 92678 | Luxembourg | Start Trial | PRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725 |
| C01280520/01 | Switzerland | Start Trial | PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
